Sangui Biotech International Inc (SBH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sangui Biotech International Inc (SBH) has a cash flow conversion efficiency ratio of 0.000x as of March 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€251.00) by net assets (€-1.01 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sangui Biotech International Inc - Cash Flow Conversion Efficiency Trend (2014–2022)
This chart illustrates how Sangui Biotech International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sangui Biotech International Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sangui Biotech International Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Clean Power Hydrogen PLC
LSE:CPH2
|
-0.397x |
|
Remington Resources Inc
V:RGM-H
|
N/A |
|
TPXimpact Holdings plc
LSE:TPX
|
0.052x |
|
GAMES BOX S.A. ZY-10
F:ZN6
|
N/A |
|
GCL Global Holdings Ltd Warrants
NASDAQ:GCLWW
|
-0.003x |
|
Lion Group Holding Ltd
NASDAQ:LGHL
|
-0.255x |
|
Guess? Inc.
NYSE:GES
|
-0.070x |
|
Metgasco Ltd
AU:MEL
|
-0.024x |
Annual Cash Flow Conversion Efficiency for Sangui Biotech International Inc (2014–2022)
The table below shows the annual cash flow conversion efficiency of Sangui Biotech International Inc from 2014 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-06-30 | €-894.96K | €-140.46K | 0.157x | -5.81% |
| 2021-06-30 | €-875.33K | €-145.85K | 0.167x | -27.78% |
| 2020-06-30 | €-729.88K | €-168.39K | 0.231x | -56.91% |
| 2019-06-30 | €-591.99K | €-316.92K | 0.535x | -25.92% |
| 2018-06-30 | €-351.14K | €-253.76K | 0.723x | -41.73% |
| 2017-06-30 | €-260.52K | €-323.10K | 1.240x | -22.22% |
| 2016-06-30 | €-247.57K | €-394.76K | 1.595x | -10.03% |
| 2015-06-30 | €-339.83K | €-602.29K | 1.772x | +101.70% |
| 2014-06-30 | €7.28K | €-760.23K | -104.485x | -- |
About Sangui Biotech International Inc
Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and woun… Read more